Furthermore, SDS-insoluble SUMO2-modified proteins largely accumulate in human HD brains compared to controls, suggesting that SUMO2 modification of various proteins could occur during HD progression (O’Rourke et al., 2013). The gene discussed is SUMO2; the disease is Huntington disease.